Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Programmable nanoparticles have shown promise in early cancer trials, and may finally fulfill the promise of nanomedicine.
New partnerships could help bring a novel class of biopharmaceutical to patients.
A startup called GenePeeks will identify recessive diseases that could show up in children of sperm-bank clients and donors.
By mimicking genetic variation in people with naturally low levels of cholesterol, drug developers are hoping to create a new drug.
Mapping how our neural circuits change under the influence of anesthesia could shed light on one of neuroscience’s most perplexing riddles: consciousness.
Advanced genetic engineering is already changing vaccine development and could make inroads into other branches of medicine.